16/04/2012 21:54

These are the references as listed in the article in this month's (April) issue of Kai Tiaki Nursing New Zealand.
References
1.    Diabetes NZ (2010). More family funding needed for Type 1 diabetes. Accessed March 2012. http://www.diabetes.org.nz/news/press_releases/more_family_funding_needed_for_type_1_diabetes
2.    Derraik, J. et al. (2012). Increasing incidence and age at diagnosis among children with Type 1 diabetes over a 20-year period in Auckland (New Zealand). PLoS One. 7(2): e32640.
3.    Khardori, R. (2012). Type 1 diabetes mellitus. Medscape Reference. Accessed March 2012. http://emedicine.medscape.com/article/117739-overview
4.    Harjutsalo, V. et al. (2011). Time trends in mortality in patients with Type 1 diabetes: Nationwide population-based cohort study. British Medical Journal. 343: d5364.
5.    Diabetes New Zealand (2007). Type 2 diabetes – outcome model update. A report prepared by Price Waterhouse Coopers. Accessed March 2012. http://www.diabetes.org.nz/resources
6.    American Diabetes Association (2007). Diagnosis and classification of diabetes mellitus. Diabetes Care, 30(suppl1): S42-S47.
7.    Lamb, W. (2011). Pediatric type 1 diabetes mellitus. Medscape Reference. Accessed March 2012. http://emedicine.medscape.com/article/919999-overview
8.    Bluestone, J., Herold, K. & Eisenbarth, G. (2010). Genetics, pathophysiology and clinical interventions in type 1 diabetes. Nature. 464: 1293-1300.
9.    Sprangers, B. et al., (2011). Otelixizumab in the treatment of Type 1 diabetes mellitus. Immunotherapy. 3(11): 1303-1306.
10.    Oikarinen, M. et al. (2012). Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes. 61(3): 687-691.
11.    McKenna, M. (2012). Diabetes mystery: Why are type 1 cases surging? Scientific American. Jan 24th. Accessed March 2012: http://www.scientificamerican.com/article.cfm?id=a-diabetes-cliffhanger
12.    McCance, K., Huether, S. et al. (2010). Pathophysiology: The biological basis for disease in adults and children. (6th ed.). Philadelphia PA: Mosby Elsevier.
13.    Raghaven, V. (2012). Diabetic ketoacidosis. Medscape reference. Accessed March 2012. http://emedicine.mescape.com/article/118361-overview
14.    Nattrass, M. (2010). Diabetic ketoacidosis. Medicine. 38(12): 667-670.
15.    Casteels, K. & Mathieu, C. (2003). Diabetic ketoacidosis. Reviews in Endocrine and Metabolic Disorders. 4: 159-166.
16.    Trachtenbarg, D. (2005). Diabetic ketoacidosis. American Family Physician 71(9): 1705-1714.
17.    Orchard, T. (2011). EnRAGEd about death in type 1 diabetes. Diabetalogica. 54(10): 2480-2482.
18.    Batuman, V. (2011). Diabetic nephropathy. Medscape Reference. Accessed March 2012. http://emedicine.medscape.com/article/238946-overview
19.    Ministry of Health (2008). National diabetes retinal screening grading system and referral guidelines 2006. Wellington: New Zealand Ministry of Health.
20.    BPAC NZ (2010). Screening for diabetic retinopathy in primary care. Accessed March 2012. http://www.bpac.org.nz/magazine/2010/august/retinopathy.asp
21.    Lin, H. (2011). Diabetic neuropathy. Medscape Reference. Accessed March 2012. http://emedicine.medscape.com/article/1170337-overview
22.    Shamoon, H., et al. (1993). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 329(14): 977-986.
23.    King, M. (2012). Insulin. The Medical Biochemistry Page. Accessed March 2012. http://themedicalbiochemistrypage.org/insulin.php
24.    Pharmac (2012). Online pharmaceutical schedule. New Zealand Pharmaceutical Management Agency. www.pharmac.govt.nz/healthpros/Schedule
25.    Cohen, D. & Carter, P. (2011). How small changes led to big profits for insulin manufacturers. British Medical Journal. 342: 18-21.
26.    Horvath, K. et al. (2007). Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus. Cochrane Database of Systematic Reviews. Art. No.: CD005613. DOI: 10.1002/14651858.CD005613.pub3.
27.    Hamdy, O. (2012) Hypoglycemia. Medscape Reference. Accessed March 2012. http://emedicine.medscape.com/article/122122-overview#a0101
28.    Heller, S. (2011). Hypoglycaemia: its pathophysiology in insulin treated diabetes and hypoglycaemia unawareness. The British Journal of Diabetes and Vascular Disease. 11(6): 6-9.
29.    Elliot, J. & Heller, S. (2011). Hypoglycaemia unawareness. Practical Diabetes. 28(5): 227-232.
30.    White, J. (2007). The contribution of medications to hypoglycaemic unawareness. Diabetes Spectrum. 20(2): 77-80.